Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06099340
Other study ID # RC22_0475
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date January 2024
Est. completion date April 2027

Study information

Verified date October 2023
Source Nantes University Hospital
Contact Raphael Gross, PU-PH
Phone 02.40.84.62.08
Email raphael.gross@chu-nantes.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Neurological disorders [such as Cerebral Vascular Accident (CVA) or Spinal Cord Injury (SCI)] are among the most costly health problems to society in industrialized countries. For those affected, they generate severe restrictions in mobility, significantly altering their quality of life. Deterioration in motor function after stroke or BM is closely linked to the level of force produced at joint level. This is influenced by adaptations (neurological and tissue) inherent to the pathophysiology of the injury, and characterized by the presence of a spastic paresis syndrome. A great deal of effort is devoted to motor neurorehabilitation (particularly physiotherapy) in the days and weeks following neurological injury. This so-called sub-acute rehabilitation phase is designed to have a positive impact on the patient's motor recovery (to prevent the development of spastic paresis), and to prevent future severe limitations in the long term. Disorders observed in the chronic phase (partial recovery of strength, severe orthopedic deformities) demonstrate the limits of current therapies. In view of the results obtained in healthy subjects, eccentric training now seems to be one of the most promising physiotherapy methods for recovering muscle strength and countering neurological disorders. However, its use in the sub-acute rehabilitation phase has never been evaluated in post-stroke or post-BM patients, either in terms of its effects on the strength developed in the strengthened muscles, or more locally on the neurological and tissue disorders found in these patients in the context of spastic paresis. The aim of this project is to evaluate the effects of an eccentric muscle-strengthening exercise protocol on neurological patients in the sub-acute phase of their neurological impairment. The protocol will be applied to the ankle joint, given its importance for walking and the significant deficits found at this level in neurological populations.We hypothesize that the strengthening protocol will improve muscle strength at the ankle, and generate beneficial adaptations to combat the spastic paresis syndrome (improved muscle activation, increased muscle length, muscle volume, etc.).


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 105
Est. completion date April 2027
Est. primary completion date April 2027
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - Patient aged between 18 and 80 years - Patient with stroke< 6 months or Patient with spinal cord injury American Spinal Injury Association (ASIA) Impairment Scale C or D (incomplete motor impairment) < 6 months (second secondary criterion). - Patient hospitalized for primary rehabilitation in the neurological PRM department of Nantes University Hospital. - Patient with plantar flexor muscle hyperactivity: spasticity rated at least 1 on the modified Ashworth scale - Patient with voluntary motricity rated at least 2 on the MRC (Medical Research Council) scale Exclusion Criteria: History of functional surgery <3 months or intramuscular injection into plantar flexors <6 months - Patient with osteoarticular lesions contraindicating rehabilitation - Patient unlikely to adhere to protocol (severe cognitive impairment) and/or non-compliant - Patient with a progressive pathology contraindicating efforts (syrinx, cancer, cardiovascular instability, etc.) - Minors, protected adults, adults unable to give consent or pregnant women.

Study Design


Intervention

Other:
muscle-strengthening program
a muscle-strengthening program applied to the ankle muscles (triceps surae and dorsal flexors) in physiotherapy, as a complement to conventional rehabilitation

Locations

Country Name City State
France Chu de Nantes Nantes

Sponsors (1)

Lead Sponsor Collaborator
Nantes University Hospital

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Maximum joint force moment The force-generating capacity of the plantar flexors will be studied by measuring the maximum joint force moment on an isokinetic ergometer 10 weeks after the start of the muscle-strengthening protocol
Secondary Measurement of joint force moment Measurement of joint force moment, performed on an isokinetic ergometer, in isometric condition 14 weeks after the start of the muscle-strengthening protocol
Secondary Measurement of joint force moment Measurement of joint force moment, performed on an isokinetic ergometer, in isometric condition 10 weeks after the start of the muscle-strengthening protocol
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06009770 - Telerehabilitation Protocols With Digital and Robotic Tools for People With Chronic Neurological Disorders N/A
Not yet recruiting NCT03638570 - Altered Connections in the Spinal Cord to Reduce Hand Impairment After Stroke N/A
Recruiting NCT05857072 - Evaluation of the Mechanisms of Weight-bearing of the Hemiplegic Limb During Table Tennis Sessions in the Framework of Post-stroke Rehabilitation : Pilot Study
Recruiting NCT05147077 - Integrated Rehabilitation in Treating Post-stroke Anxiety N/A
Recruiting NCT06301542 - Multimodal, Task-Aware Movement Assessment and Control Using Functional Electrical Stimulation
Completed NCT03639116 - Spinal Plasticity to Reduce Hand Impairment After Stroke N/A
Recruiting NCT03930121 - Transcranial Direct Current Stimulation to Enhance Training Effectiveness in Chronic Post-Stroke Aphasia N/A
Completed NCT02091739 - Clinical Study to Investigate the Efficacy and Safety of Two Dose Levels of NT 201 Versus Placebo in Treating Chronic Troublesome Sialorrhea in Various Neurological Conditions Phase 3